World's Best Scientists 2026 revealed!
Giulio Marchesini

Giulio Marchesini

D-Index & Metrics

Medicine

D-Index
111
Citations
70191
World Ranking
5236
National Ranking
167

Overview

Giulio Marchesini is affiliated with the University of Bologna in Italy and has published extensively in the field of medicine, with a particular focus on endocrinology, diabetes, metabolism, and hepatology. Their work spans multiple subfields including epidemiology, physiology, and pathology and forensic medicine.

The scientist's research encompasses a range of topics, with a concentration on liver disease diagnosis and treatment, diet, metabolism, and disease, as well as the health effects of alcohol consumption. Other areas of study include liver disease and transplantation, diabetes management and research, and the intersections among metabolism, diabetes, and cancer.

Recent publications by Giulio Marchesini include:

  • Non-alcoholic fatty liver disease: A patient guideline, 2021, JHEP Reports
  • Management of non-alcoholic fatty liver disease, 2021, BMJ
  • Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002-2033: the ITA.LI.CA database, 2021, Gut
  • Nutrition in Patients with Type 2 Diabetes: Present Knowledge and Remaining Challenges, 2021, Nutrients
  • Stress Hyperglycemia and Mortality in Subjects With Diabetes and Sepsis, 2020, Critical Care Explorations

Giulio Marchesini has collaborated frequently with a number of researchers, including:

  • Maria Letizia Petroni
  • Lucia Brodosi
  • Francesca Marchignoli
  • Santo Colosimo
  • Gianluca Svegliati-Baroni

The scientist's work has appeared repeatedly in several key publication venues such as:

  • Nutrition Metabolism and Cardiovascular Diseases
  • Digestive and Liver Disease
  • Journal of Hepatology
  • PubMed
  • Acta Diabetologica

Giulio Marchesini's research output totals 175 publications within medicine, reflecting a sustained focus on liver-related diseases and metabolic disorders distributed particularly across endocrinology, diabetes, metabolism, and epidemiology. The combination of clinical guideline development, epidemiological analysis, and metabolic disease studies forms the core of their academic contributions.

Best Publications

  • EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease

    Giulio Marchesini;Christopher P. Day;Jean Francois Dufour;Ali Canbay

  • Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

    Giulio Marchesini;Elisabetta Bugianesi;Gabriele Forlani;Fernanda Cerrelli

  • The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD

    Paul Angulo;Jason M. Hui;Giulio Marchesini;Ellisabetta Bugianesi

  • Nonalcoholic fatty liver disease a feature of the metabolic syndrome

    Giulio Marchesini;Mara Brizi;Giampaolo Bianchi;Sara Tomassetti

  • Association of nonalcoholic fatty liver disease with insulin resistance

    Giulio Marchesini;Mara Brizi;Antonio M Morselli-Labate;Giampaolo Bianchi

  • Modeling NAFLD Disease Burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030

    Chris Estes;Quentin M. Anstee;Maria Teresa Arias-Loste;Heike Bantel

  • Expanding the natural history of nonalcoholic steatohepatitis: From cryptogenic cirrhosis to hepatocellular carcinoma

    Elisabetta Bugianesi;Nicola Leone;Ester Vanni;Giulio Marchesini

  • Prevalence of and risk factors for nonalcoholic fatty liver disease: The Dionysos nutrition and liver study†‡

    Giorgio Bedogni;Lucia Miglioli;Flora Masutti;Claudio Tiribelli

  • A position statement on NAFLD/NASH based on the EASL 2009 special conference ☆

    Vlad Ratziu;Stefano Bellentani;Helena Cortez-Pinto;Chris Day

  • Insulin resistance: A metabolic pathway to chronic liver disease†

    Elisabetta Bugianesi;Arthur J. McCullough;Giulio Marchesini

  • Metformin in non-alcoholic steatohepatitis.

    Giulio Marchesini;Giampaolo Bianchi;Sara Tomassetti;Marco Zoli

  • Clinical Features and Natural History of Nonalcoholic Steatosis Syndromes

    Yngve Falck-Ytter;Zobair M. Younossi;Giulio Marchesini;Arthur J. McCullough

  • A Randomized Controlled Trial of Metformin versus Vitamin E or Prescriptive Diet in Nonalcoholic Fatty Liver Disease

    Elisabetta Bugianesi;Elena Gentilcore;Rita Manini;Stefania Natale

  • Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes.

    Anna Ludovica Fracanzani;Luca Valenti;Elisabetta Bugianesi;Marco Andreoletti

  • Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease.

    Nicola Villanova;Simona Moscatiello;Stefano Ramilli;Elisabetta Bugianesi

  • Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome.

    Amedeo Lonardo;Stefano Ballestri;Giulio Marchesini;Paul Angulo

  • Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial.

    Giulio Marchesini;Giampaolo Bianchi;Manuela Merli;Piero Amodio

  • 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial

    Carel W le Roux;Carel W le Roux;Arne Astrup;Ken Fujioka;Frank Greenway

  • Obesity-Associated Liver Disease

    Giulio Marchesini;Simona Moscatiello;Silvia Di Domizio;Gabriele Forlani

  • Factors associated with poor health-related quality of life of patients with cirrhosis

    Giulio Marchesini;Giampaolo Bianchi;Piero Amodio;Francesco Salerno

Frequent Co-Authors

Marco Zoli
Marco Zoli University of Bologna
Elisabetta Bugianesi
Elisabetta Bugianesi University of Turin
Riccardo Dalle Grave
Riccardo Dalle Grave University of Verona
Simona Calugi
Simona Calugi University of Bologna
Salvatore Petta
Salvatore Petta University of Palermo
Antonio Craxì
Antonio Craxì University of Palermo
Calogero Cammà
Calogero Cammà University of Palermo
Silvia Fargion
Silvia Fargion University of Milan
Mario Rizzetto
Mario Rizzetto University of Turin
Luca Valenti
Luca Valenti University of Milan

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a career in Medicine but want flexible learning options, numerous online healthcare degrees can help you achieve your goals. For students interested in moving into healthcare leadership, it’s important to research which online healthcare administration programs have cahme accreditation? as this can impact the quality of education and job opportunities after graduation.

Registered nurses looking to advance their credentials may benefit from exploring rn to bsn no clinical hours programs. These options can help working RNs earn their bachelor’s degree conveniently without the need for additional onsite clinicals.

For those aiming to reach the highest levels in nursing practice, there are both accelerated dnp programs online and affordable dnp programs available, making it possible to earn a Doctor of Nursing Practice degree faster and with less financial burden.

Each pathway offers unique advantages, so choose the one that best aligns with your career goals, current credentials, and preferred pace of study.

Best Scientists Citing Giulio Marchesini

Trending Scientists